https://www.selleckchem.com/pr....oducts/bms303141.htm
l patients with COVID-19 are at high risk for HAIs, especially VAPs and BSIs resulting from MDR organisms. HAIs prolong mechanical ventilation and hospitalization, and HAIs complicated by septic shock almost doubled mortality. ClinicalTrials.gov; No. NCT04388670; URL www.clinicaltrials.gov. ClinicalTrials.gov; No. NCT04388670; URL www.clinicaltrials.gov.To develop a suitable and effective vaccine against Staphylococcus aureus (S. aureus), we selected the Hla-MntC-SACOL0723 (HMS) recombinant protein with two different formulations of a
Like
Comment
Share
